Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Joint Bone Spine|April 19, 2015
Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosaEtienne Merlin, Richard Mouy, Bruno Pereira, et al.Arthritis and Rheumatism|September 29, 2011
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic featuresNicolino Ruperto, Pierre Quartier, Nico Wulffraat, et al.American Journal of Medical Genetics. Part A|August 20, 2013
The identification of MAFB mutations in eight patients with multicentric carpo-tarsal osteolysis supports genetic homogeneity but clinical variabilityCybel Mehawej, Jean-Benoît Courcet, Geneviève Baujat, et al.Pediatric Rheumatology Online Journal|March 13, 2021
Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritisGuillaume Morelle, Martin Castelle, Graziella Pinto, et al.Rheumatology International|April 12, 2018
The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Pierre Quartier, Michael Hofer, Carine Wouters, et al.The Pediatric Infectious Disease Journal|August 12, 2010
Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in FranceJulien Beauté, Gaëlle Obenga, Loïc Le Mignot, et al.Arthritis and Rheumatism|April 11, 2003
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typePierre Quartier, Pierre Taupin, Franck Bourdeaut, et al.Frontiers in Immunology|October 12, 2023
Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritisNassima Bekaddour, Nikaïa Smith, Benoit Beitz, et al.RMD Open|July 16, 2020
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexateDaniel J Lovell, Hermine I Brunner, Andreas O Reiff, et al.Plos One|April 22, 2009
Chronic granulomatous disease: the European experienceJ Merlijn van den Berg, Elsbeth van Koppen, Anders Ahlin, et al.Pageof 3